目次

Executive Summary
Market Overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2021
Market outlook: Forecast for 2021 - 2026

Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Type
Market segments
Comparison by Type
Mammalian - Market size and forecast 2021-2026
Microbial - Market size and forecast 2021-2026
Cell therapy services - Market size and forecast 2021-2026
Market opportunity by Type

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2021-2026
Europe - Market size and forecast 2021-2026
Asia - Market size and forecast 2021-2026
ROW - Market size and forecast 2021-2026
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Vendor landscape
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
AGC Biologics
Binex Co. Ltd.
Boehringer Ingelheim International GmbH
Catalent Inc.
Fujifilm Diosynth Biotechnologies USA Inc.
JRS PHARMA GmbH and Co. KG
Lonza Group Ltd.
Rentschler Biopharma SE
Samsung BioLogics Co. Ltd.
WuXi Biologics (Cayman) Inc.

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2021 - 2026 ($ million)
13: Global market: Year-over-year growth 2021 - 2026 (%)
14: Five forces analysis 2021 & 2026
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2021
21: Type - Market share 2021-2026 (%)
22: Comparison by Type
23: Mammalian - Market size and forecast 2021-2026 ($ million)
24: Mammalian - Year-over-year growth 2021-2026 (%)
25: Microbial - Market size and forecast 2021-2026 ($ million)
26: Microbial - Year-over-year growth 2021-2026 (%)
27: Cell therapy services - Market size and forecast 2021-2026 ($ million)
28: Cell therapy services - Year-over-year growth 2021-2026 (%)
29: Market opportunity by Type
30: Customer landscape
31: Market share By Geographical Landscape 2021-2026 (%)
32: Geographic comparison
33: North America - Market size and forecast 2021-2026 ($ million)
34: North America - Year-over-year growth 2021-2026 (%)
35: Europe - Market size and forecast 2021-2026 ($ million)
36: Europe - Year-over-year growth 2021-2026 (%)
37: Asia - Market size and forecast 2021-2026 ($ million)
38: Asia - Year-over-year growth 2021-2026 (%)
39: ROW - Market size and forecast 2021-2026 ($ million)
40: ROW - Year-over-year growth 2021-2026 (%)
41: Key leading countries
42: Market opportunity By Geographical Landscape ($ million)
43: Impact of drivers and challenges
44: Vendor landscape
45: Landscape disruption
46: Industry risks
47: Vendors covered
48: Market positioning of vendors
49: AGC Biologics - Overview
50: AGC Biologics - Product and service
51: AGC Biologics - Key offerings
52: AGC Biologics - Key customers
53: AGC Biologics - Segment focus
54: Binex Co. Ltd. - Overview
55: Binex Co. Ltd. - Product and service
56: Binex Co. Ltd. - Key offerings
57: Binex Co. Ltd. - Key customers
58: Binex Co. Ltd. - Segment focus
59: Boehringer Ingelheim International GmbH - Overview
60: Boehringer Ingelheim International GmbH - Business segments
61: Boehringer Ingelheim International GmbH - Key offerings
62: Boehringer Ingelheim International GmbH - Key customers
63: Boehringer Ingelheim International GmbH - Segment focus
64: Catalent Inc. - Overview
65: Catalent Inc. - Business segments
66: Catalent Inc. - Key offerings
67: Catalent Inc. - Key customers
68: Catalent Inc. - Segment focus
69: Fujifilm Diosynth Biotechnologies USA Inc. - Overview
70: Fujifilm Diosynth Biotechnologies USA Inc. - Product and service
71: Fujifilm Diosynth Biotechnologies USA Inc. - Key offerings
72: Fujifilm Diosynth Biotechnologies USA Inc. - Key customers
73: Fujifilm Diosynth Biotechnologies USA Inc. - Segment focus
74: JRS PHARMA GmbH and Co. KG - Overview
75: JRS PHARMA GmbH and Co. KG - Product and service
76: JRS PHARMA GmbH and Co. KG - Key offerings
77: JRS PHARMA GmbH and Co. KG - Key customers
78: JRS PHARMA GmbH and Co. KG - Segment focus
79: Lonza Group Ltd. - Overview
80: Lonza Group Ltd. - Business segments
81: Lonza Group Ltd. - Key offerings
82: Lonza Group Ltd. - Key customers
83: Lonza Group Ltd. - Segment focus
84: Rentschler Biopharma SE - Overview
85: Rentschler Biopharma SE - Product and service
86: Rentschler Biopharma SE - Key offerings
87: Rentschler Biopharma SE - Key customers
88: Rentschler Biopharma SE - Segment focus
89: Samsung BioLogics Co. Ltd. - Overview
90: Samsung BioLogics Co. Ltd. - Business segments
91: Samsung BioLogics Co. Ltd. - Key offerings
92: Samsung BioLogics Co. Ltd. - Key customers
93: Samsung BioLogics Co. Ltd. - Segment focus
94: WuXi Biologics (Cayman) Inc. - Overview
95: WuXi Biologics (Cayman) Inc. - Business segments
96: WuXi Biologics (Cayman) Inc. - Key offerings
97: WuXi Biologics (Cayman) Inc. - Key customers
98: WuXi Biologics (Cayman) Inc. - Segment focus
99: Currency conversion rates for US$
100: Research Methodology
101: Validation techniques employed for market sizing
102: Information sources
103: List of abbreviations